Literature DB >> 9603925

T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation.

G Pedraza-Alva1, L B Mérida, S J Burakoff, Y Rosenstein.   

Abstract

CD43, the most abundant membrane protein of T lymphocytes, is able to initiate signals that lead to Ca2+ mobilization and interleukin-2 production, yet the molecular events involved in signal transduction pathway of the CD43 molecule are only beginning to be understood. We have shown recently that cross-linking CD43 on the cell surface of human T lymphocytes with the anti-CD43 monoclonal antibody L10 leads to CD43-Fyn kinase interactions and to Fyn phosphorylation on tyrosine residues. This interaction seems to be mediated by the SH3 domain of Fyn and a proline-rich sequence located in the cytoplasmic domain of CD43. Here we show that CD43-specific activation of human T lymphocytes induced tyrosine phosphorylation of the adaptor protein Shc and of the guanine exchange factor Vav, as well as the formation of a macromolecular complex that comprises Shc, GRB2, and Vav. CD43 ligation resulted in enhanced formation of Vav.SLP-76 complexes and in the activation and nuclear translocation of ERK2. Cross-linking of the CD43 molecule in 3T3-CD43(+) cells induced luciferase activity from a construct under the control of the Fos serum responsive element. Altogether, these data suggest that the mitogen-activated protein kinase pathway is involved in CD43-dependent interleukin-2 gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603925     DOI: 10.1074/jbc.273.23.14218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

4.  Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins.

Authors:  B D Leinweber; P C Leavis; Z Grabarek; C L Wang; K G Morgan
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

5.  Novel recognition mode between Vav and Grb2 SH3 domains.

Authors:  M Nishida; K Nagata; Y Hachimori; M Horiuchi; K Ogura; V Mandiyan; J Schlessinger; F Inagaki
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.

Authors:  Annamaria de Laurentiis; Marco Gaspari; Camillo Palmieri; Cristina Falcone; Enrico Iaccino; Giuseppe Fiume; Ornella Massa; Mariorosario Masullo; Franca Maria Tuccillo; Laura Roveda; Ubaldo Prati; Olga Fierro; Immacolata Cozzolino; Giancarlo Troncone; Pierfrancesco Tassone; Giuseppe Scala; Ileana Quinto
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

7.  CD43 regulates the threshold for T cell activation by targeting Cbl functions.

Authors:  Gustavo Pedraza-Alva; Lilia B Mérida; Roxana del Rio; Nora A Fierro; Mario E Cruz-Muñoz; Norma Olivares; Erika Melchy; Vivian Igras; Georg A Holländer; Steven J Burakoff; Yvonne Rosenstein
Journal:  IUBMB Life       Date:  2011-09-09       Impact factor: 3.885

8.  CD43 is a ligand for E-selectin on CLA+ human T cells.

Authors:  Robert C Fuhlbrigge; Sandra L King; Robert Sackstein; Thomas S Kupper
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

9.  An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.

Authors:  Maria Elena Bravo-Adame; Rosario Vera-Estrella; Bronwyn J Barkla; Cecilia Martínez-Campos; Angel Flores-Alcantar; Jose Pablo Ocelotl-Oviedo; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

10.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.